Dementia and cognitive disorders

The EAN Scientific Panel on Dementia and cognitive disorders has the mission to increase knowledge and awareness of dementia among the neurological community in Europe. Dementia is the biggest threat to society and neurologists need to be prepared to face it! The panel/ sub-committee developes evidence-based guidelines, position statements and conducts research in the field of dementia care on a European level.

This  Scientific Panel comprises members from all EAN member countries.

The following tasks have been completed:

I. Development and publication of guidelines

Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain ₁₈ F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol. 2018 Oct;25(10):1201-1217. doi: 10.1111/ene.13728. 

Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M. Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Journal of Neurology; Volume 7:133-144; 2000.

Rossor M. (on behalf of the Efns Scientist Panel on Dementia). Dementia and driving: European National guidelines. European Journal of Neurology; Volume 7, Issue 6, page 745, December 2000

Waldemar G, Dubois B, Emre M, Georges J, Mc Keith IG, Rossor MN, Scheltens Ph, Tariska P and Winblad B. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. European Journal of Neurology; Volume 14, Issue 1, pages e1–e26, January 2007

Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, Sorbi S, Scheltens P; on behalf of the EFNS Scientist Panel on Dementia. EFNS guidelines for the diagnosis and management of Alzheimer's disease. European Journal of Neurology; Volume 17, Issue 10, pages 1236–1248, October 2010

Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, Nacmias B, Pasquier F, Popescu B O, Rektorova I, Religa D, Rusina R, Rossor M, Schmidt R, Stefanova E, Warren JD, Scheltens P, the EFNS Scientist Panel on Dementia and Cognitive Neurology. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. European Journal of Neurology; Volume 19, Issue 9, pages 1159–1179, September 2012

II. Conduct of surveys

Hort  J, Bartos A, Pirttilä T, Scheltens P. Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe. European Journal of Neurology. 2010 Jan; 17(1):90-6

Maruta C, Guerreiro M, de Mendonça A, Hort J, Scheltens P. The use of neuropsychological tests across Europe: the need for a consensus in the use of assessment tools for dementia. European Journal of Neurology. 2011 Feb; 18(2):279-85

III. Writing of Position Papers

M. T. Ferretti, J. Martinkova, E. Biskup, T. Benke, G. Gialdini, Z. Nedelska, K. Rauen, V. Mantua, D. Religa, J. Hort, A. Santuccione Chadha and R. Schmidt, Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology. European Journal of Neurology; 2020, 0: 1–16

IV. Active Task Forces & ongoing projects

• Update on Rehabilitation in Cognitive Neurology (Stefanie Clarke/Stefano Cappa)
• Non-degenerative Cognitive Disorders (Robert Rusina)
• Early Diagnosis of Dementia and Mild Cognitive Impairment (Jose L. Molvueno)
• Clinical Trials in Dementia (Jakub Hort)
• Ethics in AD (Dorota Religna)
• Driving in AD ( Sokratis Papageorgiou)
• MCI survey in co-operation with American Academy of Neurology (Philip Scheltens)

V. Planned Projects

• Guidelines on the diagnosis and management of Alzheimer's disease.
• Guidelines will be developed according to the GRADE system (Reinhold Schmidt).